The Form 4 filing, an SEC report of insider stock activity, was filed on November 12, 2026. The trade took place on November 11. Karen L. Burton serves as senior vice president and chief financial officer at STERIS plc (STE).
Transaction details
| Transaction | |
|---|---|
| Date of Earliest Transaction | 2026-11-11 |
| Date of Latest Transaction | 2026-11-11 |
| Buy/Sell | sell |
| Transaction Count | 1 |
| Shares Transacted | 5,880 |
| Price | $255.62 |
| Total Transaction Value | $1,503,045.60 |
| Insider | |
| Ticker Symbol | STE |
| Company | STERIS plc |
| Insider Name | Burton Karen L |
| Insider Title | Sr. Vice Pres., CFO |
| Sector - Industry | Healthcare - Medical Devices |
| Holdings | |
| Total Shares Owned After Transaction | 12,956 |
| Position Size Change | 31.22% |
| Filing | |
| Filing Date | 2026-11-12 |
| SEC Link | View filing |
FAQ
What type of transaction is this?
This was a share sale, reported under transaction code S. The transaction information also suggests a link to an exercise or conversion.
What was the average price of the transaction?
The average sale price was $255.62 per share.
How did this transaction affect the insider's holdings?
She sold 5,880 shares and reported owning 12,956 shares afterward. The sale represented 31.22% of her reported shares owned before the sale.
What's the total transaction value?
The total value was $1,503,045.60 for the one reported sale.
Are there any special circumstances around this transaction?
Yes. The sale was identified as linked to a code M exercise or conversion with the same share count. An exercise can involve using a stock option, a right to buy shares at a set price. A conversion changes one type of investment into another.
Details of the matching acquisition and the filing footnotes are unavailable here. The share-count match alone does not confirm that both transactions had the same date, account, or type of shares. It also does not confirm that the exact shares acquired were sold. The available details do not establish that the sale was required or made to pay taxes.
For research purposes only; not investment advice.